Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

May 1, 2014

Photo: Head and neck cancer screening

By VUMC News and Communications
April 30, 2014

Potential mechanism for myeloma drug’s variable toxicity

A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.

By Leigh MacMillan
April 24, 2014

VICC debuts novel neuroendocrine tumor treatment

A retired elementary school principal has become the first patient at Vanderbilt-Ingram Cancer Center to receive an investigational cancer therapy for the treatment of his neuroendocrine tumor.

By VUMC News and Communications
April 24, 2014

VICC research takes center stage at national meeting

Research led by Joan Garrett, Ph.D., research instructor in Hematology/Oncology, reveals a molecular mechanism that may explain why some forms of breast cancer become resistant to therapy.

By VUMC News and Communications
April 17, 2014

VICC’s Arteaga assumes presidency of AACR

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and Donna S. Hall Professor of Breast Cancer Research at Vanderbilt-Ingram Cancer Center (VICC), assumed the presidency of the American Association for Cancer Research (AACR) for 2014-2015 during the group’s annual meeting last week in San Diego.

By VUMC News and Communications
April 17, 2014

Free head and neck cancer screening event set for April 25

Vanderbilt-Ingram Cancer Center and the Vanderbilt Department of Otolaryngology will hold the annual head and neck cancer screening event Friday, April 25, 9 a.m. – 3 p.m. The screenings are free, open to the public and require no appointment.

By VUMC News and Communications
April 10, 2014

Photo: In good hands

The Allstate WBCA Good Works Team partnered with the Kay Yow Cancer Fund to distribute wellness kits to patients at the Vanderbilt-Ingram Cancer Center this week to celebrate the NCAA Division 1 Women’s Basketball Championship held in Nashville.
By VUMC News and Communications
April 10, 2014

Photo: Sarcoma research support

The FTL Sarcoma Fund, in partnership with the T.J. Martell Foundation, recently presented a gift to the Vanderbilt-Ingram Cancer Center in support of sarcoma research in memory of Warner Music Nashville colleague Lindsay Walleman.
By VUMC News and Communications
March 20, 2014

T.J. Martell Foundation lauds Hiebert’s research

Scott Hiebert, Ph.D., associate director of Basic Research at Vanderbilt-Ingram Cancer Center (VICC), was celebrated for his contributions to cancer research during the 6th Annual Nashville Honors Gala benefiting the T.J. Martell Foundation.
By VUMC News and Communications
March 13, 2014

A new way to target cancer-driver Ras

Vanderbilt researchers have discovered small molecules that turn off cancerous Ras signals in a new way.
By Leigh MacMillan
February 27, 2014

Probing the pathogenesis of leukemia

A new mouse model reveals gene clusters important in a treatment-resistant form of leukemia.
By Leigh MacMillan
February 20, 2014

Studies shed new light on breast cancer development

Rebecca Cook, Ph.D., assistant professor of Cancer Biology, has spent her life trying to understand what makes things grow, from seedlings in soil to tumor cells in the body.
By VUMC News and Communications
February 13, 2014

Agreement sets stage for enhanced My Cancer Genome

Vanderbilt-Ingram Cancer Center (VICC) and GenomOncology have announced an agreement for the exclusive commercial development of a decision support tool based on My Cancer Genome, an online precision cancer medicine knowledge resource for physicians, patients, caregivers and researchers.
By VUMC News and Communications
1 … 42 43 44 45 46 … 55